Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

How can we wisely incorporate immunotherapy in the clinic

Immune-checkpoint inhibitors for metastatic breast cancer

Date

22 Nov 2020

Session

How can we wisely incorporate immunotherapy in the clinic

Topics

Immunotherapy

Tumour Site

Breast Cancer

Presenters

Junji Tsurutani

Authors

J. Tsurutani

Author affiliations

Advanced Cancer Translation Research Institute, Showa University, 142-8555 - Shinagawa-ku/JP

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

22 Nov 2020

Incorporation of immunotherapy in neoadjuvant setting

Presenter: Sherene Loi

Session: How can we wisely incorporate immunotherapy in the clinic

Resources:

Slides

Webcast

22 Nov 2020

Refining patient selection: PDL1 and beyond

Presenter: Frederique Penault-Llorca

Session: How can we wisely incorporate immunotherapy in the clinic

Resources:

Slides

Webcast

22 Nov 2020

LIVE Q&A

Presenter: Seock-Ah Im

Session: How can we wisely incorporate immunotherapy in the clinic

Resources:

Webcast